Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Agnieszka Badora-Rybicka
Observed names:
A. Badora- Rybicka,
A. Badora-Rybicka,
Agnieszka Badora
Institution:
The Maria Sklodowska-Curie National Research Institute of Oncology
Observed institutions:
Shandong University,
Jinan Central Hospital,
Centrum Onkologii,
The Maria Sklodowska-Curie National Research Institute of Oncology
ORCID:
0000-0001-7064-0976
Observed ORCID:
0000-0001-7064-0976
OpenAlex ID:
A5001127020
Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio before chemotherapy as potential prognostic factors in patients with newly diagnosed epithelial ovarian cancer
2016
·
Agnieszka Badora-Rybicka
, Elżbieta Nowara
, et al.
·
ESMO Open
·
53
PDF
Association of breast cancer grade with response to neoadjuvant chemotherapy assessed postoperatively
2019
·
Michał Jarząb
, Ewa Stobiecka
, et al.
·
Polish Journal of Pathology
·
38
PDF
Hodgkin lymphoma of the elderly patients: a retrospective multicenter analysis from the Polish Lymphoma Research Group*
2018
·
Tomasz Wróbel
, Przemysław Biecek
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
10
The influence of steroid receptor status on the cardiotoxicity risk in HER2-positive breast cancer patients receiving trastuzumab
2015
·
Joanna Huszno
, Agnieszka Badora
, et al.
·
Archives of Medical Science
·
9
PDF
Treatment related toxicity in BRCA1-associated epithelial ovarian cancer – is DNA repairing impairment associated with more adverse events?
2016
·
Agnieszka Badora-Rybicka
, Magdalena Budryk
, et al.
·
Współczesna Onkologia
·
7
PDF
Pre-operative high-dose-rate brachytherapy in early-stage cervical cancer: long-term single-center results
2022
·
Sylwia Kellas-Ślęczka
, Piotr Wojcieszek
, et al.
·
Journal of Contemporary Brachytherapy
·
3
PDF
279P Prognostic significance of pre-treatment NLR and PLR in BRCA1-associated epithelial ovarian cancer–a retrospective analysis
2015
·
A. Badora-Rybicka
, M. Budryk
, et al.
·
Annals of Oncology
·
3
Pre-treatment neutrophil to lymphocyte ratio and platelet to lymphocyte ratio as potential prognostic factors in patients with newly diagnosed ovarian cancer.
2015
·
Agnieszka Badora-Rybicka
, Elzbieta Nowara
·
Journal of Clinical Oncology
·
2
Bewacyzumab w leczeniu pierwszej linii u chorej na potrójnie negatywnego raka piersi w stadium rozsiewu — opis przypadku i przegląd literatury
2014
·
Agnieszka Badora-Rybicka
, Beata Kaleta
, et al.
·
Nowotwory Journal of Oncology
·
2
PDF
Multiple primary malignancies in BRCA1 mutation carriers – two clinical cases
2013
·
Agnieszka Badora
, Beata Kaleta
, et al.
·
Ginekologia Polska
·
1
4294 The Neoadjuvant Rectal (NAR) Score as a Predictor of Early Metastatic Risk in Locally Advanced Rectal Cancer (LARC) patients treated with TNT
2026
·
Iwona Dębosz-Suwińska
, Agnieszka Badora-Rybicka
, et al.
·
Radiotherapy and Oncology
Real-world outcomes of palliative anti–programmed cell death protein 1 monotherapy in patients aged ≥75 years with advanced melanoma
2026
·
M. Gajda
, K. Maczka- Labecka
, et al.
·
EJC Skin Cancer
PDF
First-Line Cemiplimab Immunotherapy in an Elderly Patient with Concomitant Basal Cell Carcinoma and Cutaneous Squamous Cell Carcinoma: A Case Report
2026
·
A. Badora- Rybicka
, J. Brzezowski
, et al.
·
EJC Skin Cancer
Successful Cemiplimab Therapy in a Very Elderly Patient with Cutaneous Squamous Cell Carcinoma: A Case Report
2026
·
A. Bal
, M. Wisniewska
, et al.
·
EJC Skin Cancer
Unexpected Clinical and Dermoscopic Advancement of Nevoid Basal Cell Carcinoma Syndrome Despite Cemiplimab Therapy
2025
·
G. Kaminska-Winciorek
, W. Bal
, et al.
·
EJC Skin Cancer
PDF
Abstract P2-12-07: Fdg PET/CT early response prediction for triple negative breast cancer neoadjuvant chemotherapy with addition of carboplatin
2022
·
Marcin Kubeczko
, Anna Michalik
, et al.
·
Cancer Research
Abstract PS15-09: Adverse events in breast cancer patients treated with concurrent or sequential radiation therapy and CDK 4/6 inhibitors in metastatic setting
2021
·
Marcin Kubeczko
, Agnieszka Badora-Rybicka
, et al.
·
Cancer Research
Abstract P4-02-12: Association of nodal stage as assessed by FDG PET/CT with pathological complete response rate after preoperative chemotherapy
2020
·
Marcin Kubeczko
, Andrea D'Amico
, et al.
·
Cancer Research
Defining a SUV decrease cut-off in PET/CT response monitoring after one cycle of preoperative breast cancer chemotherapy
2019
·
M. Kubeczko
, K. Świderska
, et al.
·
Annals of Oncology
PDF
The efficacy of preoperative breast cancer chemotherapy without anti-HER2-targeted treatment: Single center experience in setting of no reimbursement in Poland (2011-2015)
2019
·
A. Badora-Rybicka
, A. Polakiewicz-Gilowska
, et al.
·
Annals of Oncology
Age alone or Charlson comorbidity index – what guides anticancer treatment choice in newly diagnosed, non-metastatic breast cancer in the real life setting?
2016
·
A. Badora-Rybicka
, E. Nowara
, et al.
·
Annals of Oncology
Toxicity related to first line, platinum-based chemotherapy in BRCA1-associated epithelial ovarian cancer: Is DNA repairing impairment associated with more adverse events?
2016
·
Agnieszka Badora-Rybicka
, Magdalena Budryk
, et al.
·
Journal of Clinical Oncology
The Ca125 Concentration in Intraperitoneal Fluid as A Prognostic Factor in Ovarian Cancer Patients with Refractory Malignant Ascites
2016
·
Elzbieta Nowara
, Agnieszka Badora-Rybicka
, et al.
·
Journal of Tumor
PDF
Ocena wpływu stosowania rytuksymabu na wyniki leczenia chorych na chłoniaki rozlane z dużych komórek B z obecnością zmian pozawęzłowych
2015
·
Agnieszka Badora-Rybicka
·
Nowotwory Journal of Oncology
Can laboratory parameters be predictive factors for treatment effectiveness of patients suffering from viral hepatitis C?
2015
·
Agnieszka Badora-Rybicka
, Marek Waluga
, et al.
·
Annales Academiae Medicae Silesiensis
PDF
Show more works
View as search
Works count:
31
Citation count:
128
H-index:
5
I10-index:
3
Year
Topic
Type